Detalhe da pesquisa
1.
The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/ß-catenin signaling.
Exp Hematol Oncol
; 13(1): 27, 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38438856
2.
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia.
Leukemia
; 37(2): 326-338, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376377
3.
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation.
Nat Commun
; 14(1): 97, 2023 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36609611